Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
20.0 GBX -0.80 ( 3.85%)
Last update at 2026-10-27T16:30:00Z
VOLUME
22277
Market Cap
4254.70M
P/E
0.28

Momentum Score

…

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
20.00
Low
21.60
High
52 Week Price Range
8.91
Low
17.74
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
20.80
Dividend Yield
2.92%
Revenue TTM
3946.40M
Revenue Per Share
15.75
Gross Profit TTM
1061.60M
Debt / Equity
0.63
ROE
9.17%
Net Debt
722.59M
ROCE
13.26%
Diluted EPS TTM
0.62

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2022-01-01
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2022-01-01
Income before tax 217.73M 208.00M 355.44M 225.30M -
Minority interest - 0.00M -0.10M 0.80M -
Net income 190.77M 164.70M 321.52M 199.60M -
Selling general administrative 695.30M 265.20M 179.90M 212.90M -
Selling and marketing expenses - 449.90M 475.00M 415.50M -
Gross profit 1026.51M 1165.40M 1122.22M 954.50M -
Reconciled depreciation 148.80M 156.20M 149.00M 142.50M -
Ebit 365.52M 384.38M 411.60M 223.70M 206.70M
Ebitda 520.38M 483.45M 560.60M 381.20M -
Depreciation and amortization 154.87M 99.08M 149.00M 157.50M -
Operating income 365.52M 234.70M 392.20M 223.70M -
Other operating expenses 3741.78M 3605.00M 5033.20M 5417.80M 0.80M
Interest expense 33.10M 29.77M 19.20M 19.30M 0.00M
Tax provision 25.90M 43.30M 44.70M 25.70M -
Interest income 2.40M 5.40M 9.60M 1.70M -
Net interest income -29.40M -26.80M -12.50M -20.80M -
Income tax expense 26.96M 43.30M 40.49M 25.70M 17.00M
Total revenue 4107.29M 3839.70M 5018.33M 5642.40M -
Total operating expenses 660.99M 930.70M 731.90M 729.90M -
Cost of revenue 3080.78M 2674.30M 3896.12M 4687.90M -
Total other income expense net -147.79M -26.70M -36.76M 1.60M -
Discontinued operations - - - 57.20M 26.40M
Net income from continuing ops 183.30M 164.70M 347.70M 199.60M -
Net income applicable to common shares - - - 257.60M 167.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2022-01-01
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2022-01-01
Total assets 3974.47M 3874.50M 3571.18M 3860.10M -
Intangible assets 670.38M 770.90M 809.90M 783.80M -
Other current assets 0.10M 74.80M 64.39M 409.60M 236.20M
Total liab 2047.04M 1801.70M 1640.61M 1991.70M -
Total stockholder equity 1927.43M 2072.80M 1930.57M 1861.10M -
Deferred long term liab - - - 22.40M 22.20M
Other current liab 106.81M 286.40M 410.38M 69.20M 65.90M
Common stock 18.40M 18.73M 19.80M 104.10M 17.20M
Capital stock 18.40M 19.40M 19.80M 104.10M -
Retained earnings 1743.81M 1775.20M 1830.80M 1397.70M 1381.70M
Other liab - - - 134.90M 197.70M
Good will 863.30M 837.10M 727.40M 668.30M -
Other assets - - -227.92M 91.90M 73.80M
Cash 491.26M 417.00M 413.70M 438.60M -
Total current liabilities 1218.95M 1054.50M 880.50M 1120.00M 887.40M
Current deferred revenue - - -282.08M - -
Net debt 722.59M 541.90M 358.10M 574.20M -
Short term debt 396.15M 321.60M 129.00M 276.00M -
Short long term debt 375.60M 300.80M 108.90M 258.20M -
Short long term debt total 1213.84M 958.90M 771.80M 1012.80M -
Other stockholder equity 90.41M 278.87M 79.97M 359.30M 251.90M
Property plant equipment - - - 573.30M 585.10M
Total current assets 1652.50M 1487.10M 1483.10M 1551.90M 1429.00M
Net tangible assets - - - 431.40M 379.00M
Short term investments - - 15.25M - -
Net receivables 498.16M 360.50M 445.39M 379.50M 352.40M
Long term debt 641.60M 552.20M 553.50M 639.80M -
Inventory 662.98M 634.80M 550.20M 703.70M 593.60M
Accounts payable 715.99M 344.60M 280.20M 774.80M 442.50M
Accumulated other comprehensive income 74.81M - 189.86M - -
Non currrent assets other 16.20M -114.38M 28.74M 278.10M -
Non current assets total 2321.98M 2387.40M 2316.00M 2308.20M -
Capital lease obligations 108.50M 105.90M 109.40M 114.80M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2022-01-01
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2022-01-01
Investments 1.80M -375.00M 84.00M 176.70M 1.00M
Change to liabilities - - - 0.00M 0.00M
Total cashflows from investing activities -78.89M -375.00M 84.00M 176.70M -147.30M
Net borrowings 87.20M -0.50M -130.80M -108.90M 56.00M
Total cash from financing activities -315.04M -258.40M -366.57M -390.20M -118.30M
Change to operating activities - - - 38.00M 202.00M
Net income 190.77M 164.70M 321.52M 256.80M 167.00M
Change in cash 18.25M -188.60M 112.30M 85.90M 2.90M
Begin period cash flow 473.01M 304.80M 192.50M 94.50M 94.50M
End period cash flow 491.26M 116.20M 304.80M 180.40M 94.50M
Total cash from operating activities 396.53M 443.20M 425.30M 298.30M 251.10M
Issuance of capital stock - - - 0.00M -
Depreciation 154.87M 156.20M 149.00M 142.50M 102.20M
Other cashflows from investing activities - -25.10M 74.41M -11.70M 23.20M
Dividends paid 122.60M 104.40M 97.20M 84.40M 80.50M
Change to inventory -7.39M -121.50M 176.85M -101.10M -186.10M
Change to account receivables -62.97M 116.00M -84.26M 5.60M -13.40M
Sale purchase of stock -258.94M -129.80M -148.10M -196.90M -
Other cashflows from financing activities -24.25M -23.70M 15.24M 671.90M -
Change to netincome - - - -44.30M -45.30M
Capital expenditures 51.62M 87.10M 68.63M 68.90M 49.50M
Change in working capital -13.22M -61.30M -44.12M -57.50M -
Stock based compensation 21.90M 18.20M 24.50M 18.80M -
Other non cash items 64.11M 165.40M -25.60M -62.30M -
Free cash flow 344.91M 356.10M 356.67M 229.40M -

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
GLB
Glanbia plc
-0.80
3.85%
20.00 0.28 12.38 1.08 2.44 1.36 13.84
ABF
Associated British Foods PLC
-39.00
1.98%
1927.00 13.37 12.18 0.69 1.21 0.82 6.04
KYGA
Kerry Group
-0.80
0.82%
97.00 0.17 13.30 1.60 1.85 1.94 11.32
MICC
The Magnum Ice Cream Company N.V.
-1.00
0.07%
1449.00 25.07 13.30 0.82 12.11 1.31 11.19
CWK
Cranswick PLC
-60.00
1.13%
5260.00 19.74 17.06 1.00 2.75 1.03 9.56

Profile*

Glanbia plc

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Leggetsrath Business Park, Kilkenny, Ireland, R95 YTD5

353 56 777 2200

4963

Name Title Year Born
Dr. Peter Michael Yu Ph.D. Chairman & CEO 1961
Mr. Gregory R. Armstrong CFO & Director 1977
Mr. Hugh McGuire Dip Finance, M.Sc CEO & Executive Director 1971
Mr. Mark A. Garvey CFO & Executive Director 1964
Mr. Liam Hennigan Group Secretary & Head of Investor Relations NA
Mr. Ian Doyle Chief Corporate Development Officer 1978
Mr. Tom Tench CEO Dairy Nutrition 1971
Ms. Wendy Smith Chief Digital & Transformation Officer NA
Ms. Sorcha McKenna Chief Strategy Officer NA
Mr. Steve Waters Chief Supply Chain Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…